Current chemotherapy strategies for adults with IDH-wildtype glioblastoma.

Front Oncol · 2024 · PMC11294075 · PMID 39099691

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Using inverse probability weights, an adjusted mITT analysis of these 129 patients found a nonsignificant trend towards improved survival in the lomustine/temozolomide arm (HR 0.74, 95% CI 0.47–1.17) but no difference in progression-free survival.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.